Skip to main content
. 2017 Aug;81:206–225. doi: 10.1016/j.ejca.2017.04.019

Table 4.

Patient status.

All (n = 497) VC (n = 249) VCE (n = 248)
Current status
  •  Alive, disease free

60 30 30
  •  Alive, disease present, regression

18 8 10
  •  Alive, disease present, stable

316 165 151
  •  Alive, progression/relapse

36 16 20
  •  Dead

54 25 29
  •  No information/lost to follow up

6/7 2/3 4/4
Reasons for death
  •  Tumour progression

38 19 19
  •  Metastases

5 2 3
  •  Complications of tumour or therapy

9 4 5
  •  Relation to tumour not clear

2 2
Radiotherapy (RT) for progression 59 33 26
  •  Median age at start of RT (years, q1–q3)

8.0 (6.8–11.4) 7.8 (6.7–10.2) 8.7 (7.0–11.5)
  •  Median time RT was delayed (months, q1–q3)

27.4 (8.3–51.8) 30.5 (11.9–58.4) 15.9 (6.9–51.5)